한국어
English
日本語
中文(简体)
Mylectin-En Tablets 180 mg (Sodium Mycophenolate)
192.4mg
Tablet · Prescription medication
Jongkun Dang Co., Ltd.
Mycophenolate sodium is an immunosuppressant that prevents rejection after organ transplantation.
MFDS ingredient code M264419
Mycophenolate sodium is a component of the immunosuppressant class, primarily used in organ transplant patients to suppress immune responses and prevent rejection of the transplanted organ. This component inhibits the proliferation of immune cells.
Mycophenolate sodium reduces immune responses by interfering with the synthesis of nucleic acids needed for immune cell proliferation. This suppresses the activity of immune cells that attack the transplanted organ, preventing rejection.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other immunosuppressants, mycophenolate sodium selectively inhibits specific enzymes to block the proliferation of immune cells. As a result, it has a different side effect profile and may be used in combination with other immunosuppressants.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
